Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
RANDOX LABORATORIES

Download Mobile App




Technology Breakthrough in Deep Light Imaging to Improve Disease Diagnosis

By LabMedica International staff writers
Posted on 13 Jul 2023

Optical coherence tomography (OCT), an important form of light imaging, operates on the principle of light backscattering within the sample under observation, similar to how light gets scattered in fog due to water droplets possessing different refractive indices than the air. More...

Just as the scattering makes it hard to see through fog, the scattering by cellular components and smaller constituents in biological tissue also complicates imaging tasks. Specifically, acquiring a clear signal from depths surpassing 1mm presents significant difficulties, chiefly because of intervening tissue. Now, a technological breakthrough in OCT is set to revolutionize applications in fields like ophthalmology, dermatology, cardiology, and early cancer detection, as well as improve disease diagnosis.

Traditional understanding holds that the OCT signal is largely influenced by light that has experienced a single backscattering event, while light that has been scattered numerous times hampers image creation. An international team of researchers, in collaboration with the University of St Andrews (Scotland, UK), have uncovered a contrasting perspective. They suggest that selectively gathering multiply scattered light could enhance image contrast at depth, especially in highly scattering samples. The researchers further demonstrated how this technique could be applied in a simple way with minimal additional optics, by shifting the light delivery and collection pathways. The team is confident that their ground-breaking discovery has the potential to challenge existing conventions and bring about a significant shift in retrieving images at depth.

“The unique configuration, supported by our modeling, should redefine our view on OCT signal formation – and we can now use this insight to extract more information and to improve diagnosis of disease,” said Dr. Peter Andersen, co-corresponding author from Technical University of Denmark.

Related Links:
University of St Andrews 


Gold Member
Quantitative POC Immunoassay Analyzer
EASY READER+
Online QC Software
Acusera 24•7
Prefilled Tubes
Prefilled 5.0ml Tubes
Multi-Chamber Washer-Disinfector
WD 390
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to LabMedica.com and get access to news and events that shape the world of Clinical Laboratory Medicine.
  • Free digital version edition of LabMedica International sent by email on regular basis
  • Free print version of LabMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of LabMedica International in digital format
  • Free LabMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Molecular Diagnostics

view channel
Image: New findings indicate that chimeric RNAs, once viewed as cancer byproducts, can also be part of normal physiology with regulatory functions (Image credit: Adobe Stock)

Female-Specific RNA Biomarker May Help Explain Sex Differences in Immune Disease

Women show distinct susceptibility to infectious diseases and higher rates of autoimmune disorders, yet the molecular drivers remain unclear. This gap has limited sex-specific diagnostic and prognostic tools.... Read more

Microbiology

view channel
Image: Multidrug-resistant Klebsiella pneumoniae is a growing community health concern, causing recurrent UTIs in older adults and complicating first-line antibiotic treatment (Image Credit: Adobe Stock)

Study Reveals Widespread Community Spread of Drug-Resistant Klebsiella

Multidrug-resistant Klebsiella pneumoniae is an escalating community health concern, driving recurrent urinary tract infections in older adults and complicating first-line antibiotic therapy.... Read more

Industry

view channel
Image: The proposed immunoassay uses ALZpath’s pTau217 antibody to detect Alzheimer’s disease biology in blood, supporting the growing role of blood-based biomarkers in clinical care (Photo courtesy of Shutterstock)

Agreement Supports pTau217-Based Alzheimer’s Blood Test Development

As disease-modifying therapies for Alzheimer’s disease expand, accessible diagnostics are increasingly needed to identify patients earlier. Current confirmatory methods, including PET imaging and cerebrospinal... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.